The government has decided to allow retail sale of Tamiflu, an antiviral drug that slows the spread of non-resistant strains of the influenza virus between cells in the body.
The notification for retail sale of Tamiflu will be coming in a few days from now. Six companies have been granted licence for making and distributing Tamiflu.
Tamiflu is one of two antiviral drugs said to be effective in treating the A/H1N1 flu virus that has reached pandemic levels worldwide.
